Tilray Medical Brings Global Medical Cannabis Expertise to Cannabis Europa London 2026

About this update from Tilray Brands, Inc.

[{"type":"image","alt":"Tilray Brands, Inc.","displaySize":"","headline":null,"caption":"Tilray Brands, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":91,"url":"https://media.zenfs.com/en/globenewswire.com/37713059b7a048e7e843c27a7d5468a6"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/46Rld.YJih5h.q9UKP5aIQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTEyNw--/https://media.zenfs.com/en/globenewswire.com/37713059b7a048e7e843c27a7d5468a6","width":300,"height":91},"resize_sm":{"url":"https://s.yimg.com/ny/api/res/1.2/46Rld.YJih5h.q9UKP5aIQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTEyNw--/https://media.zenfs.com/en/globenewswire.com/37713059b7a048e7e843c27a7d5468a6","width":300,"height":91}},"lazy":false},{"type":"text","content":"Industry Leaders Convene on the Future of Medical Cannabis Regulation and Patient Access","length":88,"tagName":"p"},{"type":"text","content":"LONDON, May 26, 2026 (GLOBE NEWSWIRE) -- Tilray Medical, a global leader in medical cannabis research, cultivation, production, products and distribution and a division of Tilray Brands, Inc. (“Tilray”) (Nasdaq: TLRY; TSX: TLRY), today announced its participation in Cannabis Europa London 2026, one of Europe’s leading forums for medical cannabis policy, science, and regulation.","length":385,"tagName":"p"},{"type":"text","content":"Cannabis Europa London 2026 will bring together policymakers, healthcare professionals, researchers, and industry leaders to discuss the future of medical cannabis regulation, innovation, and public health policy in Europe.","length":223,"tagName":"p"},{"type":"text","content":"José Tempero, Director of International Medical Affairs at Tilray Medical, will participate in a featured panel discussion titled, “Evidence First: Designing Public Policy Through Data and Trials,” taking place on May 26 at 12:00 p.m., at The Barbican in London.","length":262,"tagName":"p"},{"type":"text","content":"The panel will explore how European pilot programmes, clinical research, and real-world evidence are helping shape responsible, evidence-based cannabis policy frameworks across Europe. Discussions will include the role of clinical trials, public health data, patient outcomes, and scalable regulatory approaches.","length":312,"tagName":"p"},{"type":"text","content":"José Tempero, Director of International Medical Affairs, Tilray Medical, said...

More updates from Tilray Brands, Inc.